Read up on the latest news in apoptosis research. This edition contains a list of Novus' apoptosis sale products, new apoptosis publications and an editorial spotlight on Bcl-2.
Date:
Tue, 2009-09-29
APOPTOSIS NEWSLETTER - 1st Edition
Spotlight on Bcl-2 Bcl-2 suppresses apoptsois by controlling mitochondrial membrane permeability and inhibiting caspase activity by forming pores in the mitochondrial outer membrane. Despite Bcl-2’s known role in the mitochondrial mediated pathway of apoptosis, it is unknown whether Bcl-2 forms monomeric or oligomeric pores. A recent study shows that the Bcl-2 pore expands as the concentration of Bcl-2 increases, thus suggesting that the pore is formed by Bcl-2 oligomers (Peng J, et al. Apoptosis. 2009;14(10):1145-53). Bcl-2 formed pores are much smaller than the pores created via Bax action, therefore the oligomerization findings in this study support the model that Bcl-2 is a defective Bax.
Want to learn more about Apoptosis? Sign up to receive a copy of Novus’ Apoptosis Product Catalog.
Coming Soon: Customer Reviews Published on our Website IRE-1 Alpha Phosphospecific Antibody [NB100-2323]
NB100-2323 was given 5 stars in a customer review submitted on May 27, 2009. The customer conducted Western blot analysis on mouse lens tissue at a dilution of 1:1,000. A specific band was visualized at 110 kDa.
New Product Information 25% OFF select apoptosis-related antibodies and proteins. View the list here.